Oncotarget

Oncotarget · ISSN (e) 1949-2553 · 129 papers in corpus
2023
doi:10.18632/oncotarget.28447 ·PMID:37235843

The long non-coding RNA (lncRNA) MALAT1 is a regulator of oncogenesis and cancer progression. MAPK-pathway upregulation is the main event in the development and progression of human cancer, including melanoma and recent studies have shown t…

2023
doi:10.18632/oncotarget.28354 ·PMID:36738455

CD200 is an immunoregulatory cell surface ligand with proven pro-tumorigenic credentials via its ability to suppress CD200 receptor (CD200R)-expressing anti-tumor immune function. This definitive role for the CD200-CD200R axis in regulating…

2022
doi:10.18632/oncotarget.28220 ·PMID:35359749

Despite advances in understanding of ovarian cancer biology, the progress in translation of research findings into new therapies is still slow. It is associated in part with limitations of commonly used cancer models such as cell lines and …

2021
doi:10.18632/oncotarget.28161 ·PMID:34966482

The rising incidence and mortality of endometrial cancer (EC) in the United States calls for an improved understanding of the disease's progression. Current methodologies for diagnosis and treatment rely on the use of cell lines as models f…

2020
doi:10.18632/oncotarget.27715 ·PMID:32934782

IntroductionInterleukin-16 (IL-16) is a chemotactic cytokine that is found to increase in Cancer and cardiovascular diseases (CVD). Single nucleotide polymorphisms (SNPs) in IL16 were associated with diseases. Thus, we conducted a systemati…

2019
doi:10.18632/oncotarget.26950 ·PMID:31217899

We previously reported the establishment of a rare xenograft derived from a recurrent oligodendroglioma with 1p/19q codeletion. Here, we analyzed in detail the exome sequencing datasets from the recurrent oligodendroglioma (WHO grade III, r…

2019
doi:10.18632/oncotarget.26803 ·PMID:31069017

Gynaecological sarcomas account for 3-4% of all gynaecological malignancies and have a poorer prognosis compared to gynaecological carcinomas. Pivotal treatment for early-stage uterine sarcoma is represented by total hysterectomy. Whereas o…

article 2018
doi:10.18632/oncotarget.25823 ·PMID:30140375

// Roberta Fusco 1 , Ramona D’amico 1 , Marika Cordaro 1 , Enrico Gugliandolo 1 , Rosalba Siracusa 1 , Alessio Filippo Peritore 1 , Rosalia Crupi 1 , Daniela Impellizzeri 1 , Salvatore Cuzzocrea 1, 2 and Rosanna Di Paola 1 1 Department of C…

article 2018
doi:10.18632/oncotarget.24546 ·PMID:29599905

// Masako Ishikawa 1 , Kentaro Nakayama 1 , Kohei Nakamura 1 , Ruriko Ono 1 , Kaori Sanuki 1 , Hitomi Yamashita 1 , Tomoka Ishibashi 1 , Toshiko Minamoto 1 , Kouji Iida 1 , Sultana Razia 1 , Noriyoshi Ishikawa 2 and Satoru Kyo 1 1 Departmen…

2018
doi:10.18632/oncotarget.24821 ·PMID:29872493

High androgen level impairs endometrial receptivity in women experiences the recurrent miscarriage. The mechanism of androgen actions on endometrium is still uncertain. We hypothesized that androgen has a direct effect on the endometrium in…

2018
doi:10.18632/oncotarget.24959 ·PMID:29854283

IntroductionAbout 25% of ovarian cancers can be classified as hereditary. Of these, 80-90% are correleted with the Hereditary Breast-Ovarian Cancer Syndrome (HBOC), which is linked to BRCA 1/2 genes mutations. Our study was set up to study …

2018
doi:10.18632/oncotarget.23274 ·PMID:29416790

Chronic myelocytic leukemia (CML) is characterized by increased and unregulated growth of predominantly myeloid cells in the bone marrow, and accumulation of these cells in blood. We investigated the effects of an anti-malarial drug, dihydr…

2018
doi:10.18632/oncotarget.23916 ·PMID:29435182

In this paper, a retrospective cohort study was conducted to the high ovarian responders in GnRH-antagonist protocols of IVF/ICSI cycles. The purpose of the study is to investigate whether dual triggering of final oocyte maturation with a c…

other 2018
doi:10.18632/oncotarget.23747 ·PMID:29435183

Iron is proposed to contribute to the transition from endometriosis to specific subtypes of ovarian cancers (OVCAs). Regulation of intracellular iron occurs via a ferritinophagic process involving NCOA4 (Nuclear Receptor Coactivator 4), rep…

2018
doi:10.18632/oncotarget.25491 ·PMID:29930753

Neuroblastoma is a pediatric tumor of the sympatoadrenal lineage of the neural crest characterized by high molecular and clinical heterogeneity, which are the main causes of the poor response to standard multimodal therapy. The identificati…

2018
doi:10.18632/oncotarget.23155 ·PMID:29416655

ObjectiveDetection and resection of all malignant lesions is pivotal in staging and cytoreductive surgery (CRS) of endometrial cancer (EC). Intraoperative EC detection could be enhanced using OTL-38, a fluorescent-labelled folate receptor-α…

2018
doi:10.18632/oncotarget.24942 ·PMID:29755664

MicroRNAs (miRNAs) have recently demonstrated great potential and enormous promise in the diagnosis, prognosis and therapy of various types of cancer. In this study, we performed a comprehensive miRNA expression analysis in the omental meta…

2018
doi:10.18632/oncotarget.20633 ·PMID:29416620

Iodine is crucial for thyroid hormone production. However, recent epidemiologic studies have shown that breast cancer patients have an elevated risk of developing thyroid cancer and vice versa. A notable finding in this study is that iodine…

2018
doi:10.18632/oncotarget.26199 ·PMID:30410679

The demonstration that ovarian carcinoma (OC) is an immunogenic disease, opens opportunities to explore immunotherapeutic interventions to improve clinical outcome. In this regard, NK cell based immunotherapy could be promising as it has be…

other 2018
doi:10.18632/oncotarget.24555 ·PMID:29632642

Ovarian clear cell carcinoma (OCCC) exhibits distinct phenotypes, such as resistance to chemotherapy, poor prognosis and an association with endometriosis. Biomarkers and imaging techniques currently in use are not sufficient for reliable d…

2018
doi:10.18632/oncotarget.25126 ·PMID:29854318

Ovarian cancer is the fifth most common cancer affecting the female population and at present, stands as the most lethal gynecologic malignancy. Poor prognosis and low five-year survival rate are attributed to nonspecific symptoms and below…

2018
doi:10.18632/oncotarget.25613 ·PMID:29963273

Highly malignant tumors overexpress the minichromosome maintenance 2 (MCM2) protein in the nucleus, which is associated with advanced tumor grade, advanced stage, and poor prognosis. In this study, we showed that MCM2 is highly expressed in…

2018
doi:10.18632/oncotarget.26015 ·PMID:30349654

The contraceptive pill is an effective and very safe method to control pregnancies. It was developed 60 years ago, and despite, that the composition has been the same since it was first developed (estrogen and progestogen), along the years …

2018
doi:10.18632/oncotarget.24776 ·PMID:29707125

Transcription factor hepatocyte nuclear factor 1-beta (HNF-1β) enhances checkpoint kinase 1 (Chk1) activation and promotes G2/M cell cycle progression in ovarian clear cell carcinoma (CCC) following exposure to diverse genotoxic agents incl…

2017
doi:10.18632/oncotarget.15759 ·PMID:28445964

Ovarian reserve reflects a woman's fertility potential. The ABO blood group system is a very stable genetic marker. Although many recent studies have explored the relationship between ABO blood group and ovarian reserve, a consensus has not…